C4 Therapeutics Inc
NASDAQ:CCCC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C4 Therapeutics Inc
NASDAQ:CCCC
|
US |
|
Kanabo Group PLC
F:3WD
|
UK |
|
NetApp Inc
NASDAQ:NTAP
|
US |
|
PubMatic Inc
NASDAQ:PUBM
|
US |
|
M
|
Mastercard Inc
BMV:MA
|
US |
|
Moody's Corp
NYSE:MCO
|
US |
|
T
|
Tonnellerie Francois Freres SA
PAR:TFF
|
FR |
|
V
|
Vibhavadi Medical Center PCL
SET:VIBHA
|
TH |
|
P
|
Pfizer Inc
XHAM:PFE
|
US |
|
E
|
Eni SpA
XMUN:ENI
|
IT |
|
C
|
Christian Dior SE
XBER:DIO
|
FR |
|
Advance Auto Parts Inc
NYSE:AAP
|
US |
|
Barco NV
OTC:BCNAF
|
BE |
|
Installed Building Products Inc
NYSE:IBP
|
US |
|
S
|
San Miguel Corp
XPHS:SMC
|
PH |
|
N
|
NetEase Inc
HKEX:9999
|
CN |
|
T
|
Tandy Leather Factory Inc
NASDAQ:TLF
|
US |
|
A
|
American Campus Communities Inc
F:FGA
|
US |
|
ARMOUR Residential REIT Inc
NYSE:ARR
|
US |
|
Spire Global Inc
NYSE:SPIR
|
US |
|
M
|
Montana Aerospace AG
SIX:AERO
|
CH |
|
Chipotle Mexican Grill Inc
NYSE:CMG
|
US |
|
Shanghai CDXJ Digital Technology Co Ltd
SSE:603887
|
CN |
|
Dynamatic Technologies Ltd
NSE:DYNAMATECH
|
IN |
Bankruptcy Probability
C4 Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
C4 Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
C4 Therapeutics Inc
NASDAQ:CCCC
|
362.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
C4 Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, C4 Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
